You are on page 1of 2

17122 Federal Register / Vol. 71, No.

65 / Wednesday, April 5, 2006 / Notices

The meeting will be closed to the disclosure of which would constitute a Place: National Institutes of Health, Two
public in accordance with the clearly unwarranted invasion of Democracy Plaza, 6707 Democracy
provisions set forth in sections personal privacy. Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Name of Committee: National Cancer Contact Person: Lorrita Watson, PhD.,
as amended. The grant applications and Institute Special Emphasis Panel, P4 Concept National Center on Minority Health, and
the discussions could disclose Review. Health Disparities, National Institutes of
confidential trade secrets or commercial Date: April 25, 2006. Health, 6707 Democracy Blvd., Suite 800,
property such as patentable material, Time: 8 a.m. to 2 p.m. Bethesda, MD 20892–5465. (301) 402–1366.
and personal information concerning Agenda: To review and evaluate concept watsonl@ncmhd.nih.gov.
review. Name of Committee: National Center on
individuals associated with the grant Place: Residence Inn Bethesda, 7335
applications, the disclosure of which Minority Health and Health Disparities
Wisconsin Ave., Bethesda, MD 20814. Special Emphasis Panel, Loan Repayment
would constitute a clearly unwarranted Contact Person: Timothy C. Meeker, PhD, Program for Health Disparities Research—
invasion of personal privacy. Scientific Review Administrator, Special Panel C.
Name of Committee: National Cancer Review and Logistics Branch, National Date: May 12, 2006.
Institute Special Emphasis Panel, Molecular Cancer Institute, 6116 Executive Boulevard, Time: 8:30 a.m. to 5:30 p.m.
Biology. Room 8103, Bethesda, MD 20892. 301–594– Agenda: To review and evaluate grant
Date: May 22–24, 2006. 1279, meekert@mail.nih.gov. applications.
Time: 6 p.m. to 5 p.m. (Catalogue of Federal Domestic Assistance Place: National Institutes of Health, Two
Agenda: To review and evaluate grant Program Nos. 93.392, Cancer Construction; Democracy Plaza, 6707 Democracy
applications. 93.393, Cancer Cause and Prevention Boulevard, Bethesda, MD 20892 (Virtual
Place: Hilton Silver Spring, 8727 Colesville Research; 93.394, Cancer Detection and Meeting).
Road, Silver Spring, MD 20910. Diagnosis Research; 93.395, Cancer Contact Person: Lorrita Watson, PhD.,
Contact Person: Michael B. Small, PhD, Treatment Research; 93.396, Cancer Biology National Center on Minority Health, and
Scientific Review Administrator, Research Research; 93.397, Cancer Centers Support, Health Disparities, National Institutes of
Programs Review Branch, Division of 93.398, Cancer Research Manpower, 93.399, Health, 6707 Democracy Blvd., Suite 800,
Extramural Activities, National Cancer Cancer Control, National Institutes of Health, Bethesda, MD 20892–5465. (301) 402–1366.
Institute, National Institutes of Health, 6116 HHS) watsonl@ncmhd.nih.gov.
Executive Blvd., Room 8127, Bethesda, MD Dated: March 29, 2006. Dated: March 29, 2006.
20892–8328. 301–402–0996. Anna Snouffer, Anna Snouffer,
smallm@mail.nih.gov.
Acting Director, Office of Federal Advisory Acting Director, Office of Federal Advisory
(Catalogue of Federal Domestic Assistance Committee Policy. Committee Policy.
Program Nos. 93.392, Cancer Construction;
[FR Doc. 06–3223 Filed 4–4–06; 8:45 am] [FR Doc. 06–3224 Filed 4–4–06; 8:45am]
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and BILLING CODE 4140–01–M BILLING CODE 4140–01–M
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support; DEPARTMENT OF HEALTH AND DEPARTMENT OF HEALTH AND
93.398, Cancer Research Manpower; 93.399, HUMAN SERVICES HUMAN SERVICES
Cancer Control, National Institutes of Health,
HHS) National Institutes of Health National Institutes of Health
Dated: March 29, 2006.
National Center on Minority Health and National Heart, Lung, and Blood
Anna Snouffer, Health Disparities; Notice of Closed Institute; Notice of Closed Meetings
Acting Director, Office of Federal Advisory Meetings
Committee Policy. Pursuant to section 10(d) of the
[FR Doc. 06–3222 Filed 4–4–06; 8:45 am] Pursuant to section 10(d) of the Federal Advisory Committee Act, as
BILLING CODE 4140–01–M
Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
is hereby given of the following meetings.
DEPARTMENT OF HEALTH AND meetings. The meetings will be closed to the
HUMAN SERVICES The meetings will be closed to the public in accordance with the
public in accordance with the provisions set forth in sections
National Institutes of Health provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and
National Cancer Institute; Notice of as amended. The grant applications and the discussions could disclose
Closed Meeting the discussions could disclose confidential trade secrets or commercial
Pursuant to section 10(d) of the confidential trade secrets or commercial property such as patentable material,
Federal Advisory Committee Act, as property such as patentable material, and personal information concerning
amended (5 U.S.C. Appendix 2), notice and personal information concerning individuals associated with the contract
is hereby given of the following individuals associated with the grant proposals, the disclosure of which
meeting. applications, the disclosure of which would constitute a clearly unwarranted
The meeting will be closed to the would constitute a clearly unwarranted invasion of personal privacy.
public in accordance with the invasion of personal privacy. Name of Committee: National Heart, Lung,
provisions set forth in sections Name of Committee: National Center on and Blood Institute Special Emphasis Panel,
552b(c)(4) and 552b(c)(6), as amended. Minority Health and Health Disparities Long-Term Oxygen Treatment Trial.
The concept review and the discussions Special Emphasis Panel, LRP for Health Date: April 12, 2006.
wwhite on PROD1PC61 with NOTICES

could disclose confidential trade secrets Disparities & Extramural Clinical Research— Time: 7 p.m. to 11 p.m.
Panel B. Agenda: To review and evaluate contract
or commercial property such as Date: April 24, 2006. proposals.
patentable material, and personal Time: 8:30 a.m. to 5:30 p.m. Place: Hyatt Regency Bethesda, One
information concerning individuals Agenda: To review and evaluate grant Bethesda Metro Center, 7400 Wisconsin
associated with the concept review, the applications. Avenue, Bethesda, MD 20814.

VerDate Aug<31>2005 16:10 Apr 04, 2006 Jkt 208001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\05APN1.SGM 05APN1
Federal Register / Vol. 71, No. 65 / Wednesday, April 5, 2006 / Notices 17123

Contact Person: Valerie L Prenger, PhD, Place: Hyatt Regency Bethesda, One including consideration of personnel
Chief, Review Branch, Division of Extramural Bethesda Metro Center, 7400 Wisconsin qualifications and performance, and the
Affairs, National Heart, Lung, and Blood Avenue, Bethesda, MD 20814. competence of individual investigators,
Institute, 6701 Rockledge Drive, MSC 7924, Time: April 11, 2006, 8:30 a.m. to 5 p.m. the disclosure of which would
Room 7214, Bethesda, MD 20892–7924, 301– Agenda: To review and evaluate grant
435–0270, prengerv@nhlbi.nih.gov.
constitute a clearly unwarranted
applications. invasion of personal privacy.
Name of Committee: National Heart, Lung, Place: Hyatt Regency Bethesda, One
and Blood Institute Special Emphasis Panel, Bethesda Metro Center, 7400 Wisconsin Name of Committee: Board of Scientific
Long-Term Oxygen Treatment Trial. Avenue, Bethesda, MD 20814. Counselors, NIAA.
Date: April 13, 2006. Time: April 12, 2006, 8:30 a.m. to 1 p.m. Date: May 31–June 1, 2006.
Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant Open: May 31, 2006, 7:45 a.m. to 8 a.m.
Agenda: To review and evaluate contract applications. Agenda: Personal qualifications and
proposals. Place: Hyatt Regency Bethesda, One performance, and competence of individual
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin investigators.
Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Place: National Institutes of Health, 5635
Avenue, Bethesda, MD 20814. Fishers Lane, Rooms 508/509, Bethesda, MD
Contact Person: Judith A. Arroyo, PhD, 20892.
Contact Person: Valerie L Prenger, PhD, Scientific Review Administrator, National
Chief, Review Branch, Division of Extramural Institute of Alcohol Abuse and Alcoholism, Closed: May 31, 2006, 8 a.m. to 7 p.m.
Affairs, National Heart, Lung, and Blood 5635 Fishers Lane, Room 3041, Bethesda, MD Agenda: To review and evaluate review
Institute, 6701 Rockledge Drive, MSC 7924, 20892–9804. 301–443–0800. sections of the Laboratory of Molecular
Room 7214, Bethesda, MD 20892–7924, 301– jarroyo@mail.nih.gov. Physiology (LMP), and the Laboratory for
435–0270, prengerv@nhlbi.nih.gov. Integrative Neuroscience (LIN).
This notice is being published less than 15 Place: National Institutes of Health, 5635
(Catalogue of Federal Domestic Assistance days prior to the meeting due to the timing
Program Nos. 93.233, National Center for Fishers Lane, Rooms 508/509, Bethesda, MD
limitations imposed by the review and 20892.
Sleep Disorders Research; 93.837, Heart and funding cycle.
Vascular Diseases Research; 93.838, Lung Closed: June 1, 2006, 8 a.m. to 11:15 a.m.
Diseases Research; 93.839, Blood Diseases (Catalogue of Federal Domestic Assistance Agenda: To review and evaluate sections of
and Resources Research, National Institutes Program Nos. 93.271, Alcohol Research the Laboratory of Molecular Physiology
of Health, HHS) Career Development Awards for Scientists (LMP), and the Laboratory for Integrative
and Clinicians; 93.272, Alcohol National Neuroscience (LIN).
Dated: March 29, 2006. Research Service Awards for Research Place: National Institutes of Health, 5635
Anna Snouffer, Training; 93.273, Alcohol Research Program; Fishers Lane, Rooms 508/509, Bethesda, MD
Acting Director, Office of Federal Advisory 93.891, Alochol Research Center Grants, 20892.
Committee Policy. National Institutes of Health, HHS) Contact Person: Brenda L. Sandler, Chief,
[FR Doc. 06–3233 Filed 4–4–06; 8:45 am] Dated: March 28, 2006. Administrative Services Branch, NIAAA,
BILLING CODE 4140–01–M Anna Snouffer, 5635 Fishers Lane, MSC 9304, Bethesda, MD
20892–9304. 301–402–9386.
Acting Director, Office of Federal Advisory sandlerb@niaaa.nih.gov.
Committee Policy.
DEPARTMENT OF HEALTH AND (Catalogue of Federal Domestic Assistance
[FR Doc. 06–3219 Filed 4–4–06; 8:45 am] Program Nos. 93.271, Alcohol Research
HUMAN SERVICES BILLING CODE 4140–01–M Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
National Institutes of Health Research Service Awards for Research
DEPARTMENT OF HEALTH AND Training; 93.273, Alcohol Research Programs;
National Institute on Alcohol Abuse 93.891, Alcohol Research Center Grants,
and Alcoholism; Notice of Closed HUMAN SERVICES
National Institutes of Health, HHS).
Meeting National Institutes of Health Dated: March 29, 2006.
Pursuant to section 10(d) of the Anna P. Snouffer,
National Institute on Alcohol Abuse
Federal Advisory Committee Act, as Acting Director, Office of Federal Advisory
and Alcoholism; Notice of Meeting
amended (5 U.S.C. Appendix 2), notice Committee Policy.
is hereby given of the following Pursuant to section 10(d) of the [FR Doc. 06–3220 Filed 4–4–06; 8:45 am]
meeting. Federal Advisory Committee Act, as BILLING CODE 4410–01–M
The meeting will be closed to the amended (5 U.S.C. Appenfix 2), notice
public in accordance with the is hereby given of a meeting of the
provisions set forth in sections Board of Scientific Counselors, NIAAA. DEPARTMENT OF HEALTH AND
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., The meeting will be open to the HUMAN SERVICES
as amended. The grant applications and public as indicated below, with
the discussions could disclose attendance limited to space available. National Institutes of Health
confidential trade secrets or commercial Individuals who plan to attend and
need special assistance, such as sign National Institute of Child Health and
property such as patentable material,
language interpretation or other Human Development; Notice of Closed
and personal information concerning
reasonable accommodations, should Meeting
individuals associated with the grant
applications, the disclosure of which notify the Contact Person listed below Pursuant to section 10(d) of the
would constitute a clearly unwarranted in advance of the meeting. The meeting Federal Advisory Committee Act, as
invasion of personal privacy. will be closed to the public as indicated amended (5 U.S.C. Appendix 2), notice
Name of Committee: National Institute on
below in accordance with the provisions is hereby given of the following
Alcohol Abuse and Alcoholism Special set forth in section 552b(c)(6), Title 5 meeting.
wwhite on PROD1PC61 with NOTICES

Emphasis Panel. U.S.C., as amended for the review, The meeting will be closed to the
Date: April 10–12, 2006. discussion, and evaluation of individual public in accordance with the
Time: April 10, 2006, 7 p.m. to 10 p.m. intramural programs and projects provisions set forth in sections
Agenda: To review and evaluate grant conducted by the National Institute on 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
applications. Alcohol Abuse and Alcoholism, as amended. The grant applications and

VerDate Aug<31>2005 18:34 Apr 04, 2006 Jkt 208001 PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 E:\FR\FM\05APN1.SGM 05APN1

You might also like